Data protection Impressum

R&D

The applied research partnership between CSEM, the Insel Gruppe, and the University of Bern has been extended for three years, building on 32 medtech projects launched since 2023 and reinforcing Bern's ambition to become a leading international medical hub by 2030.

CSEM, Insel Gruppe, and University of Bern extend Bern medtech collaboration for three more years

20 April 2026

ONWARD Medical has secured EUR 40.6 million through an accelerated bookbuild offering led by a EUR 25 million investment from EQT Life Sciences, extending the company's cash runway into the first quarter of 2028.

ONWARD Medical raises EUR 40 million to extend ARC therapy commercialization

20 April 2026

Ecorobotix has reached a commercial milestone, with 1,000 units of its ARA ultra-high precision sprayer now deployed on farms across more than 30 countries spanning Europe, North and South America, and Oceania.

Ecorobotix reaches 1,000 ARA precision sprayers sold worldwide

24 March 2026

Konica Minolta collaborates with iPrint to develop new industrial applications for inkjet printhead technology in Europe.

Konica Minolta partners with Fribourg’s iPrint to expand inkjet applications

18 February 2026

CSEM has developed a precision mechanism at the core of Europe’s MTG-S weather satellite, enabling earlier detection of extreme weather events.

CSEM unveils key mechanism for Europe’s next-generation weather satellite

11 February 2026

Developed at Empa and EPFL, the new FireDrone is designed to operate in extreme heat, supporting firefighting operations and industrial inspections in hazardous environments.

EPFL and Empa unveil FireDrone for high-risk firefighting and industrial inspections

9 February 2026

HemostOD has been awarded a CHF 2 million Innosuisse grant to support the preclinical development of its donor-free, off-the-shelf human blood platelets for transfusion.

HemostOD secures CHF 2 million to advance donor-free platelet development

9 February 2026

The first stone of the JD7 building has been laid in Neuchâtel, marking a new milestone for the canton’s innovation district and its future microtechnology research infrastructure.

First stone laid for the JD7 building in Neuchâtel

28 January 2026

Researchers from the Francis Crick Institute and Bern-based AlveoliX have developed the first human lung-on-chip model built entirely from genetically identical cells, opening new perspectives for personalised respiratory disease research.

AlveoliX contributes to first lung-on-chip model using genetically identical human cells

19 January 2026

Researchers at CHUV have validated a new stem-cell–based method to study autoimmune diseases in organs such as the brain, offering new insights into conditions like autoimmune encephalitis and multiple sclerosis.

CHUV researchers develop new method to study autoimmune diseases

2 December 2025

1 2 3 4 5 … 17